Biolidics Limited (8YY.SI)

0.0150 +0.0010 (+7.14%) As of 09:26AM SGT. Market open.

Biolidics Limited

37 Jalan Pemimpin
No.02-07 Mapex
Singapore 577177
Singapore

https://www.biolidics.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 34

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Tang Yih Song	CEO & Exec. Director	N/A	N/A	1965
Prof. Chwee Teck Lim	Founder and Advisor	N/A	N/A	N/A
Mr. Tan Swee Jin	Co-Founder and Technical Advisor	N/A	N/A	N/A
Mr. Yeung Sau Siu CA	Financial Controller	N/A	N/A	1974
Dr. Ali Asgar Bhagat	Technical Director	N/A	N/A	N/A
Ms. Hafiza Alwi Nor	Company Sec.	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SGD.

Description

Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company provides Covid-19 PCR testing kits. It offers ClearCell FX1 System, an automated in vitro diagnostic medical device that separates and enriches cancer cells from blood; and antigen and antibody test kits, as well as laboratory services. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. Biolidics Limited was incorporated in 2009 and is based in Singapore.

Corporate governance

Biolidics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.